Hypofractionated Accelerated Concurrent Chemoradiotherapy in Inoperable Stage III Non-small Cell Lung Cancer: SOCCAR. A Large Single-Centre Experience

Madam — Recent Royal College of Radiologists' treatment guidelines for lung cancer during the COVID-19 pandemic [1] motivated us to share the findings of our recent audit of accelerated hypofractionated concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC; SOCCAR regime n): 55 Gy in 20 fractions over 26 days with concomitant chemotherapy (cisplatin and vinorelbine) [2].

Source: Clinical Oncology - July 10, 2020 Category: Radiology Authors: A. Patibandla, C. Featherstone, V. Maclaren, G. Lumsden, S. Harrow, R. Jones, A.J. Chalmers, P. McLoone, J. Hicks Tags: Letter Source Type: research